This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fearns, C. Articles by Loskutoff, D. J. Search for Related Content PubMed PubMed Citation Articles by Fearns, C. Articles by Loskutoff, D. J.

American Journal of Pathology, Vol 150, 579-590, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-alpha

C Fearns and DJ Loskutoff
Department of Vascular Biology, Scripps Research Institute, La Jolla, CA 92037, USA.

We previously demonstrated that lipopolysaccharide (LPS) induces plasminogen activator inhibitor 1 (PAI-1) gene expression primarily in endothelial cells in most organs of the mouse, with maximal induction by 3 hours. Here we show that induction in the liver occurs in a distinctly different pattern. For example, the increase in PAI-1 mRNA in liver was biphasic with an initial peak at 1 to 2 hours and a second peak at 6 to 8 hours. Moreover, in situ hybridization experiments revealed that PAI-1 mRNA was induced in both endothelial cells and hepatocytes. The endothelial cell response was monophasic and maximal between 1 and 4 hours, whereas the hepatocyte response was biphasic, peaking at 2 hours and again at 6 to 8 hours. To determine possible mechanisms involved in the induction of PAI-1 by LPS, we analyzed the tissues for changes in tumor necrosis factor (TNF)-alpha LPS caused a rapid induction of TNF-alpha mRNA in Kupffer cells, detectable within 15 minutes. Pretreatment of mice with anti-TNF antiserum before challenge with LPS reduced the subsequent increase in plasma levels of PAI-1 by 50 to 70% and significantly reduced the level of induction of PAI-1 mRNA in the liver at both early and late times. Pretreatment appeared to inhibit induction primarily within hepatocytes. These results suggest that LPS may induce PAI-1 in endothelial cells and hepatocytes by different mechanisms.

This article has been cited by other articles:

				S. Thuy, R. Ladurner, V. Volynets, S. Wagner, S. Strahl, A. Konigsrainer, K.-P. Maier, S. C. Bischoff, and I. Bergheim Nonalcoholic Fatty Liver Disease in Humans Is Associated with Increased Plasma Endotoxin and Plasminogen Activator Inhibitor 1 Concentrations and with Fructose Intake J. Nutr., August 1, 2008; 138(8): 1452 - 1455. [Abstract] [Full Text] [PDF]

				M. Sozio and D. W. Crabb Alcohol and lipid metabolism Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E10 - E16. [Abstract] [Full Text] [PDF]

				F. F. Tukov, J. P. Luyendyk, P. E. Ganey, and R. A. Roth The Role of Tumor Necrosis Factor Alpha in Lipopolysaccharide/Ranitidine-Induced Inflammatory Liver Injury Toxicol. Sci., November 1, 2007; 100(1): 267 - 280. [Abstract] [Full Text] [PDF]

				N. V. Gorlatova, J. M. Cale, H. Elokdah, D. Li, K. Fan, M. Warnock, D. L. Crandall, and D. A. Lawrence Mechanism of Inactivation of Plasminogen Activator Inhibitor-1 by a Small Molecule Inhibitor J. Biol. Chem., March 23, 2007; 282(12): 9288 - 9296. [Abstract] [Full Text] [PDF]

				I. Bergheim, J. P. Luyendyk, C. Steele, G. K. Russell, L. Guo, R. A. Roth, and G. E. Arteel Metformin Prevents Endotoxin-Induced Liver Injury after Partial Hepatectomy J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1053 - 1061. [Abstract] [Full Text] [PDF]

				K. Al-Nedawi, J. Szemraj, and C. S. Cierniewski Mast Cell-Derived Exosomes Activate Endothelial Cells to Secrete Plasminogen Activator Inhibitor Type 1 Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1744 - 1749. [Abstract] [Full Text] [PDF]

				K. Yamamoto, T. Shimokawa, H. Yi, K.-i. Isobe, T. Kojima, D. J. Loskutoff, and H. Saito Aging Accelerates Endotoxin-Induced Thrombosis : Increased Responses of Plasminogen Activator Inhibitor-1 and Lipopolysaccharide Signaling with Aging Am. J. Pathol., November 1, 2002; 161(5): 1805 - 1814. [Abstract] [Full Text] [PDF]

				W. Zhao, D. R. Spitz, L. W. Oberley, and M. E. C. Robbins Redox Modulation of the Pro-Fibrogenic Mediator Plasminogen Activator Inhibitor-1 following Ionizing Radiation Cancer Res., July 1, 2001; 61(14): 5537 - 5543. [Abstract] [Full Text] [PDF]

				A. Samoylenko, U. Roth, K. Jungermann, and T. Kietzmann The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site Blood, May 1, 2001; 97(9): 2657 - 2666. [Abstract] [Full Text] [PDF]

				M. Birgel, H. Gottschling-Zeller, K. Rohrig, and H. Hauner Role of Cytokines in the Regulation of Plasminogen Activator Inhibitor-1 Expression and Secretion in Newly Differentiated Subcutaneous Human Adipocytes Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1682 - 1687. [Abstract] [Full Text] [PDF]

				T. Kietzmann, U. Roth, and K. Jungermann Induction of the Plasminogen Activator Inhibitor-1 Gene Expression by Mild Hypoxia Via a Hypoxia Response Element Binding the Hypoxia-Inducible Factor-1 in Rat Hepatocytes Blood, December 15, 1999; 94(12): 4177 - 4185. [Abstract] [Full Text] [PDF]

				T. Seki, A. M. Healy, D. S. Fletcher, T. Noguchi, and T. D. Gelehrter IL-1beta mediates induction of hepatic type 1 plasminogen activator inhibitor in response to local tissue injury Am J Physiol Gastrointest Liver Physiol, October 1, 1999; 277(4): G801 - G809. [Abstract] [Full Text] [PDF]

				F. Samad, K. T. Uysal, S. M. Wiesbrock, M. Pandey, G. S. Hotamisligil, and D. J. Loskutoff Tumor necrosis factor alpha  is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1 PNAS, June 8, 1999; 96(12): 6902 - 6907. [Abstract] [Full Text] [PDF]